日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RETRACTED: Sharad et al. Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. Cancers 2019, 11, 1995

撤稿:Sharad 等人,《PMEPA1 亚型(a 和 b)作为雄激素和 TGF-β 信号通路选择性抑制剂的分析揭示了前列腺癌中不同的生物学和预后特征》,Cancers 2019, 11, 1995

Sharad, Shashwat; Sztupinszki, Zsófia M; Chen, Yongmei; Kuo, Claire; Ravindranath, Lakshmi; Szallasi, Zoltan; Petrovics, Gyorgy; Sreenath, Taduru L; Dobi, Albert; Rosner, Inger L; Srinivasan, Alagarsamy; Srivastava, Shiv; Cullen, Jennifer; Li, Hua

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes

非裔美国人前列腺癌患者DNA损伤修复基因的种系突变图谱突显了潜在的靶向RAD基因。

Kohaar, Indu; Zhang, Xijun; Tan, Shyh-Han; Nousome, Darryl; Babcock, Kevin; Ravindranath, Lakshmi; Sukumar, Gauthaman; Mcgrath-Martinez, Elisa; Rosenberger, John; Alba, Camille; Ali, Amina; Young, Denise; Chen, Yongmei; Cullen, Jennifer; Rosner, Inger L; Sesterhenn, Isabell A; Dobi, Albert; Chesnut, Gregory; Turner, Clesson; Dalgard, Clifton; Wilkerson, Matthew D; Pollard, Harvey B; Srivastava, Shiv; Petrovics, Gyorgy

Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression

原发性前列腺肿瘤中局灶性p53蛋白表达和淋巴血管侵犯可预测转移进展

Gesztes, William; Schafer, Cara; Young, Denise; Fox, Jesse; Jiang, Jiji; Chen, Yongmei; Kuo, Huai-Ching; Mwamukonda, Kuwong B; Dobi, Albert; Burke, Allen P; Moul, Judd W; McLeod, David G; Rosner, Inger L; Petrovics, Gyorgy; Tan, Shyh-Han; Cullen, Jennifer; Srivastava, Shiv; Sesterhenn, Isabell A

Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017

1990-2017 年接受手术的军人医疗保健受益人群中,不同种族的前列腺癌预后情况:

Oehrlein, Nathan; Streicher, Samantha A; Kuo, Huai-Ching; Chaurasia, Avinash; McFadden, Jacob; Nousome, Darryl; Chen, Yongmei; Stroup, Sean P; Musser, John; Brand, Timothy; Porter, Christopher; Rosner, Inger L; Chesnut, Gregory T; Onofaro, Kayla C; Rebbeck, Timothy R; D'Amico, Anthony; Lu-Yao, Grace; Cullen, Jennifer

Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017

1990年至2017年接受体外放射治疗的低危和预后良好-中危患者队列中,不同种族的前列腺癌治疗结果

Stroup, Sean P; Robertson, Audry H; Onofaro, Kayla C; Santomauro, Michael G; Rocco, Nicholas R; Kuo, Huai-Ching; Chaurasia, Avinash R; Streicher, Samantha; Nousome, Darryl; Brand, Timothy C; Musser, John E; Porter, Christopher R; Rosner, Inger L; Chesnut, Gregory T; D'Amico, Anthony; Lu-Yao, Grace; Cullen, Jennifer

Financial toxicity differences between chemical versus surgical androgen deprivation therapy

化学雄激素剥夺疗法与手术雄激素剥夺疗法在经济毒性方面的差异

Aragon-Ching, Jeanny B; Rosner, Inger L

Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens

基于多参数磁共振成像和磁共振引导活检标本免疫组织化学分析的根治性前列腺切除术后前列腺癌生化复发的预后特征

Harmon, Stephanie A; Gesztes, William; Young, Denise; Mehralivand, Sherif; McKinney, Yolanda; Sanford, Thomas; Sackett, Jonathan; Cullen, Jennifer; Rosner, Inger L; Srivastava, Shiv; Merino, Maria J; Wood, Bradford J; Pinto, Peter A; Choyke, Peter L; Dobi, Albert; Sesterhenn, Isabell A; Turkbey, Baris

Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer

短期恩扎卢胺单药治疗及联合免疫疗法治疗非转移性去势敏感性前列腺癌的临床和免疫学影响

Madan, Ravi A; Karzai, Fatima; Donahue, Renee N; Al-Harthy, Munjid; Bilusic, Marijo; Rosner, Inger I; Singh, Harpreet; Arlen, Philip M; Theoret, Marc R; Marté, Jennifer L; Cordes, Lisa; Couvillon, Anna; Hankin, Amy; Williams, Moniquea; Owens, Helen; Lochrin, Sarah E; Chau, Cindy H; Steinberg, Seth; Figg, William Douglas; Dahut, William; Schlom, Jeffrey; Gulley, James L

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

在新型疗法背景下,对生化复发性前列腺癌患者进行雄激素剥夺治疗的时机选择

Marshall, Catherine Handy; Chen, Yongmei; Kuo, Claire; Cullen, Jennifer; Jiang, Jiji; Rosner, Inger; Markowski, Mark; McLeod, David G; Trock, Bruce J; Eisenberger, Mario A

Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer

卡博替尼联合多西他赛和泼尼松治疗转移性去势抵抗性前列腺癌

Madan, Ravi A; Karzai, Fatima H; Al Harthy, Munjid; Petrylak, Daniel P; Kim, Joseph W; Arlen, Philip M; Rosner, Inger; Theoret, Marc R; Cordes, Lisa; Bilusic, Marijo; Peer, Cody J; Dawson, Nancy A; Couvillon, Anna; Hankin, Amy; Williams, Moniquea; Chun, Guin; Owens, Helen; Marte, Jennifer L; Lee, Min-Jung; Tomita, Yusuke; Yuno, Akira; Trepel, Jane B; Lee, Sunmin; Steinberg, Seth M; Gulley, James L; Figg, William D; Dahut, William L